In briefing documents posted on its website, the FDA said vaccine makers should follow trial participants for at least two months to rule out safety issues before seeking emergency approval.from Moneycontrol Latest News https://ift.tt/2FbxI4m
In briefing documents posted on its website, the FDA said vaccine makers should follow trial participants for at least two months to rule out safety issues before seeking emergency approval.
Post a Comment
Post a Comment
please do not enter spam link in the comment box